All Relations between asymmetrical (pato 0000616) and nitrogen monoxide

Reference Sentence Publish Date Extraction Date Species
M C St\\xc3\\xbchlinger, P S Tsao, J H Her, M Kimoto, R F Balint, J P Cook. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation vol 104 issue 21 2001 11714652 homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. 2001-12-13 2022-01-11 Not clear
M C St\\xc3\\xbchlinger, P S Tsao, J H Her, M Kimoto, R F Balint, J P Cook. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation vol 104 issue 21 2001 11714652 a number of other risk factors for cardiovascular disease may exert their adverse vascular effects in part by elevating plasma levels of asymmetric dimethylarginine (adma), an endogenous inhibitor of nitric oxide synthase. 2001-12-13 2022-01-11 Not clear
J Murray-Rust, J Leiper, M McAlister, J Phelan, S Tilley, J Santa Maria, P Vallance, N McDonal. Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase. Nature structural biology vol 8 issue 8 2001 11473257 nitric oxide synthase is inhibited by asymmetric ng-methylated derivatives of arginine whose cellular levels are controlled in part by dimethylarginine dimethylaminohydrolase (ddah, ec 3.5.3.18). 2001-08-16 2022-01-11 Not clear
J Ellis, U B Wennerholm, A Bengtsson, H Lilja, A Pettersson, B Sultan, M Wennergren, H Hagber. Levels of dimethylarginines and cytokines in mild and severe preeclampsia. Acta obstetricia et gynecologica Scandinavica vol 80 issue 7 2001 11437716 the objectives were 1. to evaluate if the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine was altered in mild and severe forms of preeclampsia, and 2. to assess the relationship between dimethylarginines and the cytokine response in preeclampsia. 2001-08-09 2022-01-11 Not clear
P Lundman, M J Eriksson, M St\\xc3\\xbchlinger, J P Cooke, A Hamsten, P Tornval. Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine. Journal of the American College of Cardiology vol 38 issue 1 2001 11451259 plasma asymmetric dimethylarginine (adma), an endogenous nitric oxide synthase inhibitor, was measured to further elucidate the mechanisms involved. 2001-08-02 2022-01-11 Not clear
P Ure\\xc3\\xb1. [Arterial hypotension in dialysis]. Nephrologie vol 22 issue 3 2001 11436665 however, new mechanisms also appear to play an-important role, namely, the dysfunction of the autonomic nervous system and the plasmatic accumulation of vasoactive substances such as adrenomedullin, nitric oxide, and asymmetric dimethyl arginine. 2001-07-19 2022-01-11 Not clear
R H B\\xc3\\xb6ger, S M Bode-B\\xc3\\xb6ge. The clinical pharmacology of L-arginine. Annual review of pharmacology and toxicology vol 41 issue 2001 11264451 the mechanism of action of l-arginine may involve nitric oxide synthase substrate provision, especially in patients with elevated levels of the endogenous no synthase inhibitor asymmetric dimethylarginine. 2001-06-14 2022-01-11 Not clear
J T Kielstein, S M Bode-B\\xc3\\xb6ger, J C Fr\\xc3\\xb6lich, H Haller, R H B\\xc3\\xb6ge. Relationship of asymmetric dimethylarginine to dialysis treatment and atherosclerotic disease. Kidney international. Supplement vol 78 issue 2001 11168975 asymmetric dimethylarginine (adma) is an endogenous inhibitor of endothelial nitric oxide (no) synthase. 2001-04-12 2022-01-11 Not clear
R H B\\xc3\\xb6ger, S M Bode-B\\xc3\\xb6ge. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases. Seminars in thrombosis and hemostasis vol 26 issue 5 2001 11129410 asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases. 2001-04-05 2022-01-11 Not clear
R H B\\xc3\\xb6ger, S M Bode-B\\xc3\\xb6ger, P S Tsao, P S Lin, J R Chan, J P Cook. An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes. Journal of the American College of Cardiology vol 36 issue 7 2001 11127475 we sought to determine whether asymmetric dimethylarginine (adma) inhibits nitric oxide (no) elaboration in cultured human endothelial cells and whether this is associated with the activation of oxidant-sensitive signaling mediating endothelial adhesiveness for monocytes. 2001-01-11 2022-01-11 Not clear
G Sancesario, M Morello, A Reiner, P Giacomini, R Massa, S Schoen, G Bernard. Nitrergic neurons make synapses on dual-input dendritic spines of neurons in the cerebral cortex and the striatum of the rat: implication for a postsynaptic action of nitric oxide. Neuroscience vol 99 issue 4 2000 10974426 the unlabeled symmetric contacts were generally about four times as abundant as the unlabeled asymmetric contacts on the nitric oxide synthase-immunoreactive neurons. 2000-11-07 2022-01-11 Not clear
G Sancesario, M Morello, A Reiner, P Giacomini, R Massa, S Schoen, G Bernard. Nitrergic neurons make synapses on dual-input dendritic spines of neurons in the cerebral cortex and the striatum of the rat: implication for a postsynaptic action of nitric oxide. Neuroscience vol 99 issue 4 2000 10974426 the spines contacted by nitric oxide synthase-immunoreactive terminals typically also received an asymmetric synaptic contact from an unlabeled axon terminal. 2000-11-07 2022-01-11 Not clear
G Sancesario, M Morello, A Reiner, P Giacomini, R Massa, S Schoen, G Bernard. Nitrergic neurons make synapses on dual-input dendritic spines of neurons in the cerebral cortex and the striatum of the rat: implication for a postsynaptic action of nitric oxide. Neuroscience vol 99 issue 4 2000 10974426 these findings suggest that: (i) nitric oxide synthase-immunoreactive neurons in the cortex and striatum preponderantly receive inhibitory input; (ii) nitric oxide synthase-containing terminals commonly make synaptic contact with target structures in the cortex and striatum; (iii) spines targeted by nitric oxide synthase-containing terminals in the cortex and striatum commonly receive an asymmetric contact as well, which may provide a basis for a synaptic interaction of nitric oxide with excitatory input to individual spines. 2000-11-07 2022-01-11 Not clear
J P Cook. Does ADMA cause endothelial dysfunction? Arteriosclerosis, thrombosis, and vascular biology vol 20 issue 9 2000 10978245 asymmetric dimethylarginine (adma) is an endogenous and competitive inhibitor of nitric oxide synthase. 2000-10-12 2022-01-11 Not clear
C D Goonasekera, V Shah, D D Rees, M J Dillo. Vascular endothelial cell activation associated with increased plasma asymmetric dimethyl arginine in children and young adults with hypertension: a basis for atheroma? Blood pressure vol 9 issue 1 2000 10854003 to explore the role of vascular endothelium-generated nitric oxide (a known mediator of leucocyte-platelet-endothelial interactions) in this context, we investigated markers of endothelial activation (soluble vascular cell adhesion molecule-1 (vcam-1), intercellular adhesion molecule-1 (icam-1), p-selectin, e-selectin), and von willebrand factor and the plasma level of the endogenous nitric oxide inhibitor asymmetric dimethyl arginine (adma) in a group of 31 (17 male, mean age 9.4 years) hypertensive and 9 (4 male, mean age 9.1 years) healthy, normotensive children and young adults. 2000-09-27 2022-01-11 Not clear
E Causs\\xc3\\xa9, N Siri, J F Arnal, C Bayle, P Malatray, P Valdigui\\xc3\\xa9, R Salvayre, F Couder. Determination of asymmetrical dimethylarginine by capillary electrophoresis-laser-induced fluorescence. Journal of chromatography. B, Biomedical sciences and applications vol 741 issue 1 2000 10839134 asymmetric dimethyl-l-arginine (adma) is a naturally occurring analogue of l-arginine (l-arg), the substrate of nitric oxide synthase (nos). 2000-09-20 2022-01-11 Not clear
R H B\\xc3\\xb6ger, S M Bode-B\\xc3\\xb6ger, K Sydow, D D Heistad, S R Lent. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. Arteriosclerosis, thrombosis, and vascular biology vol 20 issue 6 2000 10845872 plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. 2000-06-22 2022-01-11 Not clear
R H B\\xc3\\xb6ger, S M Bode-B\\xc3\\xb6ger, K Sydow, D D Heistad, S R Lent. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. Arteriosclerosis, thrombosis, and vascular biology vol 20 issue 6 2000 10845872 we tested the hypothesis that hyperhomocyst(e)inemia is associated with an elevated plasma concentration of asymmetric dimethylarginine (adma), an endogenous inhibitor of nitric oxide synthase. 2000-06-22 2022-01-11 Not clear
J R Chan, R H B\\xc3\\xb6ger, S M Bode-B\\xc3\\xb6ger, O Tangphao, P S Tsao, T F Blaschke, J P Cook. Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans. Arteriosclerosis, thrombosis, and vascular biology vol 20 issue 4 2000 10764670 asymmetric dimethylarginine (adma), an endogenous inhibitor of nitric oxide synthase, is elevated in hypercholesterolemia. 2000-04-27 2022-01-11 Not clear
J Leiper, P Vallanc. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovascular research vol 43 issue 3 2000 10690326 of the three known methylarginine residues produced in mammals only asymmetrically methylated forms (l-nmma and asymmetric dimethylarginine (adma)) but not symmetrically methylated arginine (symmetric dimethylarginine (sdma)) inhibit nitric oxide synthase (nos). 2000-03-10 2022-01-10 Not clear
Page: 
1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50   51   52   53   54